Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of Novel Treatment for Opiate Withdrawal
Significant Progress Made in Advancing the Development of PRN-001-01(Tezampanel); Appoints New Board Members in Preparation for Launch of Phase 1 Clinical Study Series B Financing Co-led by Accelerator Life Science Partners and ARCH Venture Partners…